This is a preprint.
Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure
- PMID: 33594340
- PMCID: PMC7885912
Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure
Update in
-
Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure.mSystems. 2021 Oct 26;6(5):e0009521. doi: 10.1128/mSystems.00095-21. Epub 2021 Oct 26. mSystems. 2021. PMID: 34698547 Free PMC article.
Abstract
The novel coronavirus SARS-CoV-2, which emerged in late 2019, has since spread around the world and infected hundreds of millions of people with coronavirus disease 2019 (COVID-19). While this viral species was unknown prior to January 2020, its similarity to other coronaviruses that infect humans has allowed for rapid insight into the mechanisms that it uses to infect human hosts, as well as the ways in which the human immune system can respond. Here, we contextualize SARS-CoV-2 among other coronaviruses and identify what is known and what can be inferred about its behavior once inside a human host. Because the genomic content of coronaviruses, which specifies the virus's structure, is highly conserved, early genomic analysis provided a significant head start in predicting viral pathogenesis and in understanding potential differences among variants. The pathogenesis of the virus offers insights into symptomatology, transmission, and individual susceptibility. Additionally, prior research into interactions between the human immune system and coronaviruses has identified how these viruses can evade the immune system's protective mechanisms. We also explore systems-level research into the regulatory and proteomic effects of SARS-CoV-2 infection and the immune response. Understanding the structure and behavior of the virus serves to contextualize the many facets of the COVID-19 pandemic and can influence efforts to control the virus and treat the disease.
Conflict of interest statement
Competing Interests AuthorCompeting InterestsLast ReviewedHalie M. RandoNone2021-01-20Adam L. MacLeanNone2021-02-23Alexandra J. LeeNone2020-11-09Ronan LordanNone2020-11-03Sandipan RayNone2020-11-11Vikas BansalNone2021-01-25Ashwin N. SkellyNone2020-11-11Elizabeth SellNone2020-11-11John J. DziakNone2020-11-11Lamonica ShinholsterNone2020-11-11Lucy D’Agostino McGowanReceived consulting fees from Acelity and Sanofi in the past five years2020-11-10Marouen Ben GuebilaNone2021-08-02Nils WellhausenNone2020-11-03Sergey KnyazevNone2020-11-11Simina M. BocaCurrently an employee at AstraZeneca, Gaithersburg, MD, USA, may own stock or stock options.2021-07-01Stephen CaponeNone2020-11-11Yanjun QiNone2020-07-09YoSon ParkYoSon Park is affiliated with Pfizer Worldwide Research. The author has no financial interests to declare and contributed as an author prior to joining Pfizer, and the work was not part of a Pfizer collaboration nor was it funded by Pfizer.2020-01-22Yuchen SunNone2020-11-11David MaiNone2021-01-08Joel D BoerckelNone2021-03-26Christian BruefferEmployee and shareholder of SAGA Diagnostics AB.2020-11-11James Brian ByrdFunded by FastGrants to conduct a COVID-19-related clinical trial2020-11-12Jeremy P. KamilTBD2021-04-30Jinhui WangNone2021-01-21Ryan VelazquezNone2020-11-10Gregory L SzetoNone2020-11-16John P. BartonNone2020-11-11Rishi Raj GoelNone2021-01-20Serghei MangulNone2020-11-11Tiago LubianaNone2020-11-11COVID-19 Review ConsortiumNone2021-01-16Anthony GitterFiled a patent application with the Wisconsin Alumni Research Foundation related to classifying activated T cells2020-11-10Casey S. GreeneNone2021-01-20
Figures

Similar articles
-
Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure.mSystems. 2021 Oct 26;6(5):e0009521. doi: 10.1128/mSystems.00095-21. Epub 2021 Oct 26. mSystems. 2021. PMID: 34698547 Free PMC article.
-
Epidemiology and Genomic Characterization of Two Novel SARS-Related Coronaviruses in Horseshoe Bats from Guangdong, China.mBio. 2022 Jun 28;13(3):e0046322. doi: 10.1128/mbio.00463-22. Epub 2022 Apr 25. mBio. 2022. PMID: 35467426 Free PMC article.
-
Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.J Virol. 2020 Aug 17;94(17):e00565-20. doi: 10.1128/JVI.00565-20. Print 2020 Aug 17. J Virol. 2020. PMID: 32554697 Free PMC article.
-
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26. Drug Resist Updat. 2020. PMID: 33132205 Free PMC article. Review.
-
Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.OMICS. 2020 Nov;24(11):634-644. doi: 10.1089/omi.2020.0131. Epub 2020 Sep 16. OMICS. 2020. PMID: 32940573 Review.
References
-
- Coronavirus Disease 2019 (COVID-19) - Symptoms CDC Centers for Disease Control and Prevention (2020-December-22) https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
-
- WHO Declares COVID-19 a Pandemic Cucinotta Domenico, Vanelli Maurizio Acta Bio Medica Atenei Parmensis (2020-March-19) https://doi.org/ggq86h DOI: 10.23750/abm.v91i1.9397 - DOI - PMC - PubMed
-
- Acute lung injury in patients with COVID 19 infection Li Liyang, Huang Qihong, Wang Diane C, Ingbar David H, Wang Xiangdong Clinical and Translational Medicine (2020-March-31) https://doi.org/ghqcrz DOI: 10.1002/ctm2.16 - DOI - PMC - PubMed
-
- A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases — Wuhan, China 2019−2020 Tan Wenjie, Zhao Xiang, Ma Xuejun, Wang Wenling, Niu Peihua, Xu Wenbo, Gao George F., Wu Guizhen, MHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, China CDC, Beijing, China, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Beijing, China China CDC Weekly (2020) https://doi.org/gg8z47 DOI: 10.46234/ccdcw2020.017 - DOI - PubMed
-
- Structure, Function, and Evolution of Coronavirus Spike Proteins Li Fang Annual Review of Virology (2016-September-29) https://doi.org/ggr7gv DOI: 10.1146/annurev-virology-110615-042301 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous